Notice of Intent to Publish a Funding Opportunity Announcement for Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1), Clinical Trial Optional
ID: 353687Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353687
Timeline
    Description

    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the "Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1)" grant. This grant aims to advance scholarship on the ethical, legal, and social implications of advances in human genetics or genomics. It also aims to enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce. The NOFO is expected to be published in the summer of 2024, with an application due date in the fall of 2024. The grant will utilize the UM1 activity code, which is a Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional. The estimated total program funding is $2,600,000, and it is expected to award 4 grants. The estimated award date and project start date are both September 1, 2025.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program," aimed at fostering transdisciplinary ELSI research among underrepresented domestic organizations. The program seeks applications from entities that have received less than $30 million in NIH funding annually over the past three years, focusing on enhancing community engagement, building research capacity, and developing a diverse workforce in the field of genomics. With an anticipated funding amount of approximately $4.8 million for up to four awards, projects can last up to five years, and applicants must adhere to specific guidelines and deadlines, with submissions due by August 2, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)" to support research that investigates the ethical, legal, and social implications of human genetics and genomics. This grant encourages applications that utilize a variety of research methods, including empirical qualitative and quantitative approaches, to address significant ELSI issues arising from advancements in genomic technologies. The initiative aims to foster community engagement, particularly with historically underserved populations in genomic research, reflecting a commitment to ethical considerations in scientific progress. Grants of up to $275,000 are available for projects spanning two to three years, with application deadlines starting January 19, 2024, and funding decisions expected by July 2024. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the Ethical, Legal, and Social Implications (ELSI) Congress, supported by a cooperative agreement aimed at enhancing collaboration within the multidisciplinary ELSI research community. The initiative seeks to fund three biennial congresses that will facilitate research sharing, promote accessibility through hybrid formats, and encourage participation from underrepresented groups, particularly focusing on early-career scholars and trainees. With a budget of $350,000 allocated for the first congress scheduled for 2026, applications are due by November 19, 2024. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-028.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Environmental Health Disparities Centers (P50)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Environmental Health Disparities Centers (P50) program, aimed at addressing environmental health disparities and promoting environmental justice. This initiative will focus on research and training that targets NIH-designated health disparities populations, particularly racial and ethnic minorities, socioeconomically disadvantaged groups, and individuals from rural or under-resourced areas, in alignment with recent executive orders on environmental justice. The anticipated NOFO is expected to be released in Summer 2024, with applications due in Fall 2024, and the estimated award date is set for July 1, 2025. Interested applicants should prepare to develop responsive applications as further details will be provided in the forthcoming announcement.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to solicit applications for collaborative, multi-site research focused on advancing the diagnosis, management, and treatment of rare diseases, with an emphasis on addressing unmet clinical trial readiness needs. The funding, estimated at $1 million, will support specialized centers through cooperative agreements, with the NOFO expected to be published in winter 2024 and applications due in summer 2024. Interested applicants should prepare to develop meaningful collaborations, as the estimated award date is set for July 1, 2025.
    Notice of Intent to Publish a Notice of Funding Opportunity for National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a Notice of Funding Opportunity (NOFO) for the National Centers for Biomedical Imaging and Bioengineering (NCBIB), with a focus on advancing research in biomedical imaging and bioengineering. This grant opportunity, identified as P41 Clinical Trials Optional, aims to foster meaningful collaborations and innovative projects within the research community. The anticipated funding amount for this initiative is up to $750,000, with the NOFO expected to be published in late summer 2023 and applications due in fall 2023. Interested applicants should prepare for the estimated project start date of July 30, 2024, and can expect the award announcement by June 30, 2024.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.